Status:

UNKNOWN

Microvascular Decompressive Surgery for Hemifacial Spasm

Lead Sponsor:

Assiut University

Conditions:

Hemifacial Spasm

Eligibility:

All Genders

20-60 years

Brief Summary

* Review the clinical outcomes of Micro vascular decompression of Hemi facial Spasm. * Assess safety and efficacy of Micro vascular decompression. * Improve the outcome of these patients and decease r...

Detailed Description

Hemi facial spasm (HFS), a term described in 1905 by Babinski but first reported by Schultz in 1875, is a highly morbid movement disorder characterized by intermittent involuntary movement of muscles ...

Eligibility Criteria

Inclusion

  • Primary Hemi facial spasm Unilateral Adults 20-60 years Clinical Diagnosis confirmed by Facial Evoked potential \& Neuroimaging

Exclusion

  • Secondary Hemi facial spasm caused by intracranial masses or other lesions Recurrent Hemi facial spasm Patients who are unfit for any neurosurgical interventions.

Key Trial Info

Start Date :

September 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2023

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04474977

Start Date

September 1 2020

End Date

March 1 2023

Last Update

July 17 2020

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Microvascular Decompressive Surgery for Hemifacial Spasm | DecenTrialz